Clinical Trial Update: Dextran Use for Primary Angioplasty Protection in Acute Myocardial Infarction [NA]

View source ↗

Summary

A clinical trial update investigates using Dextran to protect during primary angioplasty in patients with ST-elevation myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• Dextran (Dextran)

Snippet

Sponsor: Centro Cardiovascular Salta | Conditions: Acute Myocardial Infarction With ST Elevation | NA | Status: UNKNOWN